Subclasses list- 200 NATURAL RESINS OR DERIVATIVES (E.G., WOOD OR PINE TAR; CATIVO RESIN DERIVATIVES, ETC.)
Patents: 37 Patent Applications: 10 - 201 Shellac containing starting material used in process, or product thereof (e.g., lac, sticklac, seedlac, flake shellac, bleached shellac, etc.)
Patents: 10 Patent Applications: 2 - 202 Cut wood starting material used in process, or product thereof (e.g., using pine stumps, chips, bark, etc., as starting material)
Patents: 12 Patent Applications: 3 - 203 Plant sap or fossil starting material used in process, or product thereof (e.g., using copal, coal, amber, dammar, etc., as starting material)
Patents: 11 Patent Applications: 0 - 204 Pine oleoresin starting material used in process, or product thereof (e.g., using gum turpentine, pine gum, pine resin, etc., as starting material)
Patents: 7 Patent Applications: 2 - 205 Recovery of tall oil or derivatives from papermaking waste, purification of tall oil, or separation of components of tall oil; or product thereof (e.g., separation of rosin, fatty acids, sterols, etc.; decolorizing, etc.)
Patents: 44 Patent Applications: 8 - 206 Organic sulfur or nitrogen containing material used in the process, or product thereof
Patents: 13 Patent Applications: 1 - 207 Esterification used in the process, or product thereof
Patents: 9 Patent Applications: 0 - 208 Inorganic material used in the process, or product thereof (e.g., using sulfuric acid, boric acid, etc.)
Patents: 32 Patent Applications: 2 - 209 Phosphorus or heavy metal containing material, elemental hydrogen, sulfur dioxide, or carbon dioxide used in the process, or product thereof
Patents: 12 Patent Applications: 2 - 210 Rosin or derivative used as starting material in process, or product thereof (e.g., using gum rosin, wood rosin, solid tall oil rosin, etc.)
Patents: 55 Patent Applications: 9 - 211 Polymerization or product thereof (e.g., dimer rosin, etc.)
Patents: 39 Patent Applications: 2 - 212 Chemical treatment or color modification of polymerized rosin or derivative, or product thereof (e.g., hydrogenation or esterification of polymerized rosin; removal of color bodies from polymerized rosin, etc.)
Patents: 29 Patent Applications: 0 - 213 Boron or phosphorus containing material used in the process, or product thereof
Patents: 23 Patent Applications: 1 - 214 Diels-Alder adducts (e.g., of maleic anhydride, fumaric acid, etc., with conjugated dienes, such as rosin acids, terpenes, etc.)
Patents: 40 Patent Applications: 1 - 215 Esterification of rosin or derivative via carboxyl group, or product thereof
Patents: 40 Patent Applications: 3 - 216 Chemical treatment or color modification of esterified rosin or derivative, or product thereof (e.g., partial saponification of rosin triglycerides; removal of color bodies from rosin esters, etc.)
Patents: 25 Patent Applications: 2 - 217 Oxygen containing ring or halogen containing material used in the esterification, or product thereof (e.g., using alkylene oxides, polysaccharides, alkyl halides, etc.)
Patents: 26 Patent Applications: 0 - 218 Polyhydroxy material used in the esterification, or product thereof (e.g., forming ester gum, etc.)
Patents: 54 Patent Applications: 2 - 219 Sulfur, selenium, or tellurium containing material used in the process, or product thereof (e.g., disproportionation of rosin, etc.)
Patents: 17 Patent Applications: 0 - 220 The sulfur, selenium, or tellurium containing material is inorganic
Patents: 10 Patent Applications: 0 - 221 Nitrogen containing material used in the process, or product thereof
Patents: 29 Patent Applications: 0 - 222 The nitrogen containing material is inorganic
Patents: 4 Patent Applications: 0 - 223 Hydrogenation or product thereof (e.g., forming dihydro rosin acids; rosinyl alcohol or derivatives; etc.)
Patents: 12 Patent Applications: 0 - 224 Metal containing material used to form salts of rosin acids, or product thereof
Patents: 13 Patent Applications: 0 - 225 Alkali metal containing material (i.e., Li, Na, K, Rb or Cs)
Patents: 8 Patent Applications: 0 - 226 Heat treatment of rosin or derivative in the absence of nonrosin organic reactants, or product thereof (e.g., forming rosin oil; disproportionated, dehydrogenated, or isomerized rosin; etc.)
Patents: 11 Patent Applications: 0 - 227 Metal, halogen, or silicon containing material used in the process, or product thereof (e.g., using clay, zeolites, etc.)
Patents: 12 Patent Applications: 0 - 228 Purification process or product thereof
Patents: 6 Patent Applications: 1 - 229 Immiscible solvents used in the process, or product thereof
Patents: 2 Patent Applications: 0 - 230 Tall oil or derivative used as starting material in process, or product thereof (e.g., metal salts of tall oil fatty acids; tall oil pitch, etc.) dehydrogenated, or isomerized rosin; etc.)
Patents: 61 Patent Applications: 7 - 231 Nitrogen containing material used in the process, or product thereof
Patents: 32 Patent Applications: 1 - 232 Esterification of tall oil acids, or product thereof
Patents: 32 Patent Applications: 1 - 233 Sulfur, boron, phosphorus, or iodine containing material used in the process, or product thereof
Patents: 16 Patent Applications: 0 - 300 PEPTIDES OF 3 TO 100 AMINO ACID RESIDUES
Patents: 5175 Patent Applications: 1772 - 301 Thymopoietin or Lipotropin; related peptides
Patents: 46 Patent Applications: 2 - 302 Endorphin and Enkephalin; related peptides
Patents: 185 Patent Applications: 8 - 303 Insulin; related peptides
Patents: 500 Patent Applications: 259 - 304 Metal complexes, e.g., Zn-insulin, etc.
Patents: 102 Patent Applications: 9 - 305 Isolation or purification
Patents: 106 Patent Applications: 9 - 306 Corticotropin (ATCH); related peptides
Patents: 59 Patent Applications: 6 - 307 Calcitonin; related peptides
Patents: 183 Patent Applications: 38 - 308 Glucagon; related peptides
Patents: 155 Patent Applications: 110 - 309 Secretin or gastrin; related peptides
Patents: 49 Patent Applications: 13 - 310 Gramicidin or Tyrocidin; related peptides
Patents: 7 Patent Applications: 1 - 311 Somatostatin (SRIF); related peptides
Patents: 283 Patent Applications: 46 - 312 Melanotropin (MSH) or eledoisin; related peptides
Patents: 39 Patent Applications: 8 - 313 Lutenizing hormone releasing factor (LRF); related peptides
Patents: 267 Patent Applications: 11 - 314 Bradykinin; kallidin; related peptides
Patents: 73 Patent Applications: 5 - 315 Oxytocin; vasopressin; related peptides
Patents: 101 Patent Applications: 18 - 316 Angiotensin; related peptides
Patents: 61 Patent Applications: 9 - 317 Cyclic peptides
Patents: 1283 Patent Applications: 663 - 318 The cyclisation occurring through the 4-amino radical of 2,4-diamino butanoic acid
Patents: 49 Patent Applications: 3 - 319 Polymyxin; related peptides
Patents: 28 Patent Applications: 6 - 320 Bacitracin; related peptides
Patents: 32 Patent Applications: 5 - 321 Containing only normal peptide links in the ring, i.e., homodetic cyclic peptides
Patents: 201 Patent Applications: 152 - 322 Peptides containing saccharide radicals, e.g., bleomycins, etc.
Patents: 554 Patent Applications: 646 - 323 Peptides with at least one nonpeptide bond other than a disulfide bond joining two or more sequences of amino acid residues, e.g., homomeric heterodectic peptide other than cyclic disulfide, depsipeptides, etc.
Patents: 416 Patent Applications: 155 - 324 25 or more amino acid residues in defined sequence
Patents: 3830 Patent Applications: 2741 - 325 24 amino acid residues in defined sequence
Patents: 997 Patent Applications: 795 - 326 15 to 23 amino acid residues in defined sequence
Patents: 2427 Patent Applications: 2241 - 327 11 to 14 amino acid residues in defined sequence
Patents: 1935 Patent Applications: 1797 - 328 8 to 10 amino acid residues in defined sequence
Patents: 2229 Patent Applications: 1966 - 329 6 to 7 amino acid residues in defined sequence
Patents: 1586 Patent Applications: 1328 - 330 4 to 5 amino acid residues in defined sequence
Patents: 1785 Patent Applications: 1119 - 331 Tripeptides, e.g., tripeptide thyroliberin (TRH), melanostatin (MIF), etc.
Patents: 1536 Patent Applications: 737 - 332 Containing at least one abnormal peptide link, e.g., gamma peptide bonded, etc.
Patents: 315 Patent Applications: 23 - 333 Synthesis of peptides
Patents: 765 Patent Applications: 255 - 334 Polymer supported synthesis, e.g., solid phase synthesis, Merrifield synthesis, etc.
Patents: 628 Patent Applications: 57 - 335 Protecting or removing protective groups, e.g., carboxyl group protection, etc.
Patents: 224 Patent Applications: 19 - 336 Of side chain or sulfur containing group
Patents: 125 Patent Applications: 9 - 337 Of amino group
Patents: 144 Patent Applications: 11 - 338 Solution phase synthesis
Patents: 187 Patent Applications: 23 - 339 Segment condensation, e.g., Ugi condensation, etc.
Patents: 75 Patent Applications: 1 - 340 With phosphorus containing material
Patents: 29 Patent Applications: 2 - 341 With use of carbonimide or imidiazole
Patents: 26 Patent Applications: 3 - 342 Mixed anhydride synthesis
Patents: 27 Patent Applications: 1 - 343 By hydrolysis
Patents: 80 Patent Applications: 5 - 344 Separation or purification
Patents: 478 Patent Applications: 160 - 345 Chemical aftertreatment, e.g., acylation, methylation, etc.
Patents: 873 Patent Applications: 269 - 350 PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES
Patents: 13953 Patent Applications: 10318 - 351 Lymphokines, e.g., interferons, interlukins, etc.
Patents: 2300 Patent Applications: 1079 - 352 Phosphoproteins, e.g., phosvitin, vitellogenin, etc.
Patents: 132 Patent Applications: 106 - 353 Scleroproteins, e.g., fibroin, elastin, silk, etc.
Patents: 141 Patent Applications: 104 - 354 Gelatin
Patents: 229 Patent Applications: 66 - 355 Separation, purification or synthesis
Patents: 86 Patent Applications: 11 - 356 Collagen
Patents: 607 Patent Applications: 220 - 357 Keratin
Patents: 87 Patent Applications: 31 - 358 Nucleoproteins, e.g., chromatin, chromosomal proteins, histones, protamines, salmine, etc.
Patents: 220 Patent Applications: 148 - 359 Lipoproteins, e.g., egg yolk proteins, cylomicrons, etc.
Patents: 187 Patent Applications: 161 - 360 Casein or caseinate
Patents: 129 Patent Applications: 24 - 361 Separation, purification or synthesis
Patents: 72 Patent Applications: 4 - 362 Albumin
Patents: 241 Patent Applications: 171 - 363 Serum albumin, e.g., BSA, HSA, etc.
Patents: 481 Patent Applications: 236 - 364 Separation, purification or synthesis
Patents: 175 Patent Applications: 37 - 365 Lactalbumin, e.g., milk source, etc.
Patents: 61 Patent Applications: 7 - 366 Separation, purification or synthesis
Patents: 66 Patent Applications: 5 - 367 Ovalalbumin, e.g., avidin, conalbumins, etc.
Patents: 82 Patent Applications: 67 - 368 Separation, purification or synthesis
Patents: 15 Patent Applications: 13 - 369 Separation, purification or synthesis
Patents: 28 Patent Applications: 17 - 370 Plant proteins, e.g., derived from legumes, algae or lichens, etc.
Patents: 674 Patent Applications: 595 - 371 Derived from fungi, e.g., yeasts, mushroom, etc.
Patents: 129 Patent Applications: 32 - 372 Derived from grain, e.g., prolamines, etc.
Patents: 115 Patent Applications: 43 - 373 Zein
Patents: 41 Patent Applications: 131 - 374 Gluten or gliadin
Patents: 74 Patent Applications: 10 - 375 Derived from wheat
Patents: 76 Patent Applications: 23 - 376 Derived from corn
Patents: 72 Patent Applications: 245 - 377 Derived from oil seed, e.g., cotton seed, rapeseed, sunflower, etc.
Patents: 197 Patent Applications: 53 - 378 Derived from soybean
Patents: 254 Patent Applications: 449 - 379 Derived from leafy green plants, e.g., alfalfa pollen, etc.
Patents: 130 Patent Applications: 41 - 380 Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc.
Patents: 967 Patent Applications: 121 - 381 Blood coagulation factors and fibrin, e.g., thromboplastin, etc.
Patents: 485 Patent Applications: 106 - 382 Fibrin or fibrin intermediates, e.g., fibrinogen, etc.
Patents: 309 Patent Applications: 63 - 383 Blood coagulation factor VIII, AHF
Patents: 435 Patent Applications: 252 - 384 Blood coagulation factor II or factor II + VII + IX + X, i.e., prothrombin complex or factor
Patents: 268 Patent Applications: 49 - 385 Hemoglobins or globins
Patents: 436 Patent Applications: 81 - 386 Globulins
Patents: 213 Patent Applications: 37 - 387.1 Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed
Patents: 3111 Patent Applications: 1662 - 387.2 Anti-idiotypic
Patents: 204 Patent Applications: 150 - 387.3 Chimeric, mutated, or recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rFv, immunoglobulin fusion protein, etc.)
Patents: 2098 Patent Applications: 3548 - 387.5 Binds oligosaccharide structure
Patents: 187 Patent Applications: 73 - 387.7 Binds expression product of cancer-related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.)
Patents: 551 Patent Applications: 205 - 387.9 Binds specifically-identified amino acid sequence
Patents: 1489 Patent Applications: 2931 - 388.1 Monoclonal
Patents: 2065 Patent Applications: 651 - 388.15 Human
Patents: 553 Patent Applications: 281 - 388.2 Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.)
Patents: 853 Patent Applications: 186 - 388.21 Binds nucleic acid or derivative or component thereof (e.g., DNA, RNA, DNA-RNA hybrid, nucleotide, nucleoside, carcinogen-DNA adduct, etc.)
Patents: 62 Patent Applications: 3 - 388.22 Binds receptor (e.g., transferrin receptor, Fc receptor, dihydropyridine receptor, IL-2 receptor, etc.)
Patents: 1032 Patent Applications: 197 - 388.23 Binds lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, or intercellular mediator specific for a hematopoietic cell (e.g., interleukin, interferon, erythropoietin, etc.)
Patents: 505 Patent Applications: 101 - 388.24 Binds hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, intragonadal regulatory protein, Mullerian inhibiting substance, inhibin, epidermal growth factor, nerve growth factor, dopamine, norepinephrine, etc.)
Patents: 385 Patent Applications: 52 - 388.25 Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.)
Patents: 428 Patent Applications: 14 - 388.26 Binds enzyme
Patents: 316 Patent Applications: 80 - 388.3 Binds virus or component or product thereof (e.g., virus-associated antigen, etc.)
Patents: 259 Patent Applications: 101 - 388.35 Binds retrovirus or component or product thereof (e.g., HIV, LAV, HTLV, etc.)
Patents: 176 Patent Applications: 12 - 388.4 Binds bacterium or similar microorganism or component or product thereof (e.g., Stretococcus, Legionella, Mycoplasma, bacterium-associated antigen, exotoxin, etc.)
Patents: 292 Patent Applications: 72 - 388.5 Binds fungus or plant cell or component or product thereof (e.g., fungus-associated antigen, etc.)
Patents: 70 Patent Applications: 7 - 388.6 Binds parasitic protozoan or metazoan cell or component or product thereof (e.g., Dirofilaria, Eimeria, Coccidia, Trichinella, parasite cell-surface antigen, etc.)
Patents: 112 Patent Applications: 5 - 388.7 Binds hematopoietic cell or component or product thereof (e.g., erythrocyte granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell-surface antigen, hemoglobin, thrombospondin, glycophorin, etc.)
Patents: 433 Patent Applications: 11 - 388.73 Binds lymphocytic or lymphocytic-like cell or component or product thereof (e.g., B cell, B-lineage bone marrow cell, null cell, natural killer cell, B-lymphoblastoid cell, B-lineage acute lymphoblastic leukemia cell, B-lymphocytic cell-surface antigen, etc.)
Patents: 368 Patent Applications: 9 - 388.75 Binds T-lymphocytic cell or component or product thereof (e.g., T cell, thymocyte, T-lineage bone marrow cell, T-lymphoblastoid cell, T-lineage acute lymphoblastic leukemia cell, T-lymphocytic cell-surface antigen, etc.)
Patents: 367 Patent Applications: 8 - 388.8 Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.)
Patents: 681 Patent Applications: 43 - 388.85 Binds antigen characterized by name or molecular weight (e.g., CEA, NCA, CC glycoprotein, melanoma gp 150 antigen, etc.)
Patents: 701 Patent Applications: 34 - 388.9 Binds drug, hapten, hapten--carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.)
Patents: 284 Patent Applications: 68 - 389.1 Polyclonal antibody or immunogloblin of identified binding specificity
Patents: 926 Patent Applications: 928 - 389.2 Binds hormone, lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, glucagon, cardiodilatin, interleukin, interferon, norepinephrine, epinephrine, acetylcholine, etc.)
Patents: 450 Patent Applications: 391 - 389.3 Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.)
Patents: 271 Patent Applications: 57 - 389.4 Binds virus or component or product thereof (e.g., virus-associated antigen, etc.)
Patents: 220 Patent Applications: 163 - 389.5 Binds bacterium or similar microorganism or component or product thereof (e.g., Pseudomonas, Chlamydia, Clostridium, bacterium-associated antigen, etc.)
Patents: 203 Patent Applications: 133 - 389.6 Binds hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, bone marrow cell, lymphocyte, leukemic cell, hematopoietic cell-surface antigen, hemoglobin, etc.)
Patents: 214 Patent Applications: 135 - 389.7 Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.)
Patents: 327 Patent Applications: 196 - 389.8 Binds drug, hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.)
Patents: 351 Patent Applications: 290 - 390.1 Removing or inactivating virus or bacterium or component or product thereof (e.g., endotoxin, etc.)
Patents: 115 Patent Applications: 7 - 390.5 Removing, dissociating, or preventing the formation of aggregated, denatured, fragmented, or polymerized immunoglobulin or antibody; or preventing or reducing complement fixation or binding; or reducing antigenicity; or removing, inactivating, or inhibiting contaminating plasma proteins (e.g., proteolytic enzymes, etc.)
Patents: 135 Patent Applications: 14 - 391.1 Monoclonal or polyclonal antibody or immunoglobulin or fragment thereof that is conjugated or adsorbed (e.g., adsorbed to a solid support, etc.)
Patents: 874 Patent Applications: 701 - 391.3 Conjugated to a detectable label or radioisotope or radionuclide or heavy metal-containing compound
Patents: 971 Patent Applications: 907 - 391.5 Conjugated via a specifically-identified linking group, chelating group, coordination complex, coupling agent, or conjugation agent
Patents: 407 Patent Applications: 49 - 391.7 Conjugated to a cytotoxic agent, drug, or other biologically-active substance
Patents: 628 Patent Applications: 913 - 391.9 Conjugated via a specifically-identified linking group, coupling agent, or conjugation agent
Patents: 345 Patent Applications: 142 - 392 Alpha globulins, e.g., ceruloplastin, haptoglobins, etc.
Patents: 98 Patent Applications: 13 - 393 Antithrombin III
Patents: 55 Patent Applications: 7 - 394 Beta globulins, e.g., transferrin, etc.
Patents: 97 Patent Applications: 77 - 395 Glycoprotein, e.g., mucins proteoglycans, etc.
Patents: 1681 Patent Applications: 962 - 396 Lectins, e.g., concanavalin, hemagglutinin, etc.
Patents: 141 Patent Applications: 101 - 397 Glycoprotein hormones
Patents: 322 Patent Applications: 152 - 398 Gonadatropins
Patents: 131 Patent Applications: 35 - 399 Hormones, e.g., prolactin, thymosin, growth factors, etc.
Patents: 1880 Patent Applications: 946 - 400 Metal containing, e.g., chromoproteins, ferritin, ferredoxins, etc.
Patents: 184 Patent Applications: 207 - 401 Cytochromes, e.g., chlorophyl, orgotein, etc.
Patents: 37 Patent Applications: 14 - 402 Chemical modification or the reaction product thereof, e.g., covalent attachment or coupling, etc.
Patents: 1747 Patent Applications: 806 - 403 Protein is identified as an antigen, e.g., immunogenic carriers, etc.
Patents: 841 Patent Applications: 117 - 404 Sulfur containing reactant
Patents: 331 Patent Applications: 12 - 405 Nitrogen containing reactant
Patents: 597 Patent Applications: 78 - 406 Oxygen containing reactant
Patents: 286 Patent Applications: 14 - 407 Hydrolysis of protein
Patents: 130 Patent Applications: 13 - 408 Sulfur containing reactant
Patents: 355 Patent Applications: 113 - 409 Nitrogen containing reactant
Patents: 490 Patent Applications: 504 - 410 Oxygen containing reactant
Patents: 339 Patent Applications: 119 - 411 Oxygen containing is saccharide
Patents: 83 Patent Applications: 17 - 412 Separation or purification
Patents: 1453 Patent Applications: 327 - 413 Immunological separation or affinity chromatography
Patents: 1181 Patent Applications: 193 - 414 Ultra filtration or osmosis
Patents: 274 Patent Applications: 44 - 415 Selective absorbtion, e.g., Ca phosphate sorbents, etc.
Patents: 336 Patent Applications: 42 - 416 Ion exchange
Patents: 649 Patent Applications: 112 - 417 Chromatography or by septum selective as to material, e.g., gel filtration, molecular sieve dialysis, etc.
Patents: 766 Patent Applications: 69 - 418 Precipitation
Patents: 293 Patent Applications: 33 - 419 With added material
Patents: 237 Patent Applications: 14 - 420 Inorganic
Patents: 203 Patent Applications: 3 - 421 Polymeric, e.g., polyethylene glycol, etc.
Patents: 128 Patent Applications: 14 - 422 Solvent extraction
Patents: 202 Patent Applications: 42 - 423 Oxygenated material
Patents: 68 Patent Applications: 11 - 424 Alcohol
Patents: 82 Patent Applications: 11 - 425 Carboxyl containing
Patents: 38 Patent Applications: 8 - 426 Hydrocarbon or halogenated hydrocarbon
Patents: 27 Patent Applications: 2 - 427 Physical treatment
Patents: 325 Patent Applications: 33 - 500 LIGNINS OR DERIVATIVES
Patents: 119 Patent Applications: 89 - 501 Aldehyde, ketone or ozone reacted with a lignin or lignin containing substance, or product thereof
Patents: 62 Patent Applications: 8 - 502 Compound which includes phenolic hydroxy or oxygen containing hetero ring reacted with a lignin or lignin containing substance, or product thereof
Patents: 55 Patent Applications: 15 - 503 Hydrogenation of a lignin or lignin containing substance, or product thereof
Patents: 3 Patent Applications: 2 - 504 Carboxylic acid anhydride, or a compound having halogen bonded directly to acyclic carbon by nonionic bonding, reacted with a lignin or lignin containing substance, or product thereof
Patents: 23 Patent Applications: 6 - 505 Compound containing nitrogen attached directly or indirectly to carbon by nonionic bonding reacted with a lignin or lignin containing substance, or product therof
Patents: 33 Patent Applications: 5 - 506 Heavy metal, aluminum, silicon or phosphorus containing
Patents: 39 Patent Applications: 3 - 507 Processes utilizing an organic solvent or a compound having alcoholic hydroxy bonded directly to an acyclic carbon, or product thereof
Patents: 43 Patent Applications: 20 - 800 ANTIHYPERTENSIVE PEPTIDES
Patents: 80 Patent Applications: 0 - 801 PEPTIDE SWEETNERS
Patents: 57 Patent Applications: 0 - 802 CHROMOGENIC OR LUMINESCENT PEPTIDES
Patents: 78 Patent Applications: 0 - 806 ANTIGENIC PEPTIDES OR PROTEINS
Patents: 629 Patent Applications: 0 - 807 HAPTEN CONJUGATED WITH PEPTIDE OR PROTEIN
Patents: 224 Patent Applications: 0 - 808 MATERIALS AND PRODUCTS RELATED TO GENETIC ENGINEERING OR HYBRID OR FUSED CELL TECHNOLOGY, E.G., HYBRIDOMA, MONOCLONAL PRODUCTS, ETC.
Patents: 291 Patent Applications: 1 - 809 Fused cells, e.g., hybridoma, etc.
Patents: 236 Patent Applications: 0 - 810 CARRIER - BOUND OR IMMOBILIZED PEPTIDES OR PROTEINS AND THE PREPARATION THEREOF, E.G., BIOLOGICAL CELL OR CELL FRAGMENT AS CARRIER, ETC.
Patents: 237 Patent Applications: 0 - 811 Peptides or proteins is immobilized on, or in, an inorganic carrier
Patents: 188 Patent Applications: 0 - 812 Peptides or proteins is immobilized on, or in, an organic carrier
Patents: 259 Patent Applications: 0 - 813 Carrier is a saccharide
Patents: 153 Patent Applications: 0 - 814 Cellulose or derivatives thereof
Patents: 106 Patent Applications: 0 - 815 Carrier is a synthetic polymer
Patents: 278 Patent Applications: 0 - 816 Attached to the carrier via a bridging agent
Patents: 251 Patent Applications: 0 - 817 Entrapped within the carrier, e.g., gel, hollow fibre, etc.
Patents: 60 Patent Applications: 0 - 820 PROTEINS FROM MICRO-ORGANISMS
Patents: 154 Patent Applications: 0 - 821 Separation of nucleic acid
Patents: 33 Patent Applications: 0 - 822 Protozoa
Patents: 61 Patent Applications: 0 - 823 Lower fungi, e.g., mold, etc.
Patents: 35 Patent Applications: 0 - 824 Yeasts
Patents: 77 Patent Applications: 0 - 825 Bacteria
Patents: 525 Patent Applications: 1 - 826 Viruses
Patents: 273 Patent Applications: 3 - 827 PROTEINS FROM MAMMALS OR BIRDS
Patents: 130 Patent Applications: 0 - 828 Cancer
Patents: 255 Patent Applications: 0 - 829 Blood
Patents: 239 Patent Applications: 0 - 830 Plasma; serum
Patents: 341 Patent Applications: 0 - 831 Cohn fractions
Patents: 86 Patent Applications: 0 - 832 Milk; colostrum
Patents: 96 Patent Applications: 0 - 833 Whey; cheese
Patents: 91 Patent Applications: 1 - 834 Urine; urinary system
Patents: 47 Patent Applications: 0 - 835 Kidney
Patents: 22 Patent Applications: 0 - 836 Mucus; mucous glands; bursa; arthral fluid; spinal fluid
Patents: 6 Patent Applications: 0 - 837 Lymph; lymph-glands; thymus
Patents: 45 Patent Applications: 0 - 838 Marrow; spleen
Patents: 30 Patent Applications: 0 - 839 Nerves; brain
Patents: 73 Patent Applications: 0 - 840 Bones; tendons; teeth; cartilage
Patents: 109 Patent Applications: 1 - 841 Muscles; heart
Patents: 31 Patent Applications: 0 - 842 Skin; hair; nails; sebaceous glands; cerumen
Patents: 43 Patent Applications: 0 - 843 Digestive system
Patents: 10 Patent Applications: 0 - 844 Stomach; intestine
Patents: 12 Patent Applications: 0 - 845 Pancreas
Patents: 15 Patent Applications: 0 - 846 Liver
Patents: 25 Patent Applications: 0 - 847 Bile
Patents: 1 Patent Applications: 0 - 848 Lungs
Patents: 25 Patent Applications: 0 - 849 Eyes; vessels; umbilical cord
Patents: 12 Patent Applications: 0 - 850 Reproductive organs or embryos
Patents: 45 Patent Applications: 0 - 851 Placenta; amniotic fluid
Patents: 81 Patent Applications: 0 - 852 Sperm
Patents: 21 Patent Applications: 0 - 853 Ovary; eggs; embryos
Patents: 55 Patent Applications: 0 - 854 Glands
Patents: 49 Patent Applications: 0 - 855 PROTEINS FROM ANIMALS OTHER THAN MAMMALS OR BIRDS
Patents: 62 Patent Applications: 0 - 856 Snakes; venom
Patents: 36 Patent Applications: 0 - 857 Fish; fish eggs; shell fish; crustacea
Patents: 82 Patent Applications: 1 - 858 Insects; venom
Patents: 76 Patent Applications: 1 - 859 WASTE, WASTE MATERIAL, REFUSE OR SLUDGE, E.G., EFFLUENTS, FECAL MATTER, ETC.
Patents: 40 Patent Applications: 0 - 860 RENIN INHIBITORS
Patents: 135 Patent Applications: 0 - 861 INVOLVING IGG3, IGG4, IGA, OR IGY
Patents: 105 Patent Applications: 0 - 862 INVOLVING IGE OR IGD
Patents: 44 Patent Applications: 0 - 863 INVOLVING IGM
Patents: 51 Patent Applications: 0 - 864 Monoclonal
Patents: 117 Patent Applications: 0 - 865 Human
Patents: 34 Patent Applications: 0 - 866 INVOLVING IMMUNOGLOBULIN OR ANTIBODY FRAGMENT, (E.G., F(AB)'2, FAB', FAB, FV, FC, HEAVY CHAIN, LIGHT CHAIN, ETC.)
Patents: 228 Patent Applications: 0 - 867 INVOLVING IMMUNOGLOBULIN OR ANTIBODY PRODUCED VIA RECOMBINANT DNA TECHNOLOGY
Patents: 67 Patent Applications: 0 - 868 INVOLVING AUTOIMMUNITY, ALLERGY, IMMEDIATE HYPERSENSITIVITY, DELAYED HYPERSENSITIVITY, IMMUNOSUPPRESSION, OR IMMUNOTOLERANCE
Patents: 226 Patent Applications: 0
| |
Bizarre Patents 
PatentStorm News
Patents 
